Phenotype and Molecular Detection of Clarithromycin and Levofloxacin Resistance in Helicobacter pylori Clinical Isolates in Beijing

References

• Malfertheiner P, Megraud F, O’Morain CA, et al. Management of helicobacter pylori infection–the maastricht iv/florence consensus report. GUT. 2012;61(5):646–664. doi:10.1136/gutjnl-2012-30208422491499
   PubMed Web of Science ®Google Scholar
• Williams MP, Pounder RE. Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol. 1999;94(11 Suppl):S11–6. doi:10.1016/S0002-9270(99)00657-710565604
   PubMed Web of Science ®Google Scholar
• Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. LANCET. 1984;1(8390):1311–1315. doi:10.1016/S0140-6736(84)91816-66145023
   PubMed Web of Science ®Google Scholar
• Atherton JC, Peek RJ, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. GASTROENTEROLOGY. 1997;112(1):92–99. doi:10.1016/S0016-5085(97)70223-38978347
   PubMed Web of Science ®Google Scholar
• Logan RP, Berg DE. Genetic diversity of Helicobacter pylori. LANCET. 1996;348(9040):1462–1463.8942769
   PubMed Web of Science ®Google Scholar
• Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of helicobacter pylori associated with cytotoxicity and duodenal ulcer. P NATL ACAD SCI USA. 1993;90(12):5791–5795. doi:10.1073/pnas.90.12.5791
   PubMed Web of Science ®Google Scholar
• Hatakeyama M. Helicobacter pylori CagA—a bacterial intruder conspiring gastric carcinogenesis. Int J Cancer. 2006;119(6):1217–1223. doi:10.1002/ijc.2183116557568
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004;113(3):321–333. doi:10.1172/JCI2092514755326
   PubMed Web of Science ®Google Scholar
• Dinis-Ribeiro M, Areia M, de Vries AC, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European society of gastrointestinal endoscopy (ESGE), European helicobacter study group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). ENDOSCOPY. 2012;44(1):74–94. doi:10.1055/s-0031-129149122198778
   PubMed Web of Science ®Google Scholar
• Vakil N, Megraud F. Eradication therapy for Helicobacter pylori. GASTROENTEROLOGY. 2007;133(3):985–1001. doi:10.1053/j.gastro.2007.07.00817854602
   PubMed Web of Science ®Google Scholar
• Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. LANCET. 2008;372(9636):392–397. doi:10.1016/S0140-6736(08)61159-918675689
   PubMed Web of Science ®Google Scholar
• Banic M, Franceschi F, Babic Z, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. HELICOBACTER. 2012;17(Suppl 1):49–55. doi:10.1111/j.1523-5378.2012.00983.x
   Web of Science ®Google Scholar
• Hooi J, Lai WY, Ng WK, et al. Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. GASTROENTEROLOGY. 2017;153(2):420–429. doi:10.1053/j.gastro.2017.04.02228456631
   PubMed Web of Science ®Google Scholar
• Li M, Gao F. Progress in research on therapeutic regimen for helicobacter pylori eradication. Chin J Gastroenter. 2016;10:623–625.
   Google Scholar
• Fifth Chinese LW. National consensus report on the management of helicobacter pylori infection. Chin J Gastroenter. 2017;6:321–324.
   Google Scholar
• Graham DY, Lee SY. How to effectively use bismuth quadruple therapy: the good, the bad, and the ugly. GASTROENTEROL CLIN N. 2015;44(3):537–563. doi:10.1016/j.gtc.2015.05.003
   PubMed Web of Science ®Google Scholar
• Fallone CA, Chiba N, van Zanten SV, et al. The toronto consensus for the treatment of helicobacter pylori infection in adults. GASTROENTEROLOGY. 2016;151(1):51–69. doi:10.1053/j.gastro.2016.04.00627102658
   PubMed Web of Science ®Google Scholar
• Gumurdulu Y, Serin E, Ozer B, et al. Low eradication rate of Helicobacter pylori with triple 7–14 days and quadruple therapy in Turkey. World J Gastroenterol. 2004;10(5):668–671. doi:10.3748/wjg.v10.i5.66814991935
   PubMed Web of Science ®Google Scholar
• Mascellino MT, Porowska B, De Angelis M, Oliva A. Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection. Drug design devther. 2017;11(2209–2220).
   Google Scholar
• Group CHPR, Gastroenterology CSO, Hong C, Fulian HU, Yong X, Pinjin HU. Prevalence of helicobacter pylori resistance to antibiotics and its influence on the treatment outcome in china: a multicenter clinical study. Chin J Gastroenter. 2007;9:525–530.
   Google Scholar
• Malfertheiner P, Megraud F, O’Morain CA, et al. Management of helicobacter pylori infection—the maastricht v/florence consensus report. GUT. 2016;66(1):6–30.27707777
   PubMed Web of Science ®Google Scholar
• Nishizawa T, Suzuki H. Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing. Fron Mol Biosci. 2014;1. doi:10.3389/fmolb.2014.00019
   Google Scholar
• Cattoir V, Nectoux J, Lascols C, et al. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. Int J Antimicrob Agents. 2007;29(4):389–396. doi:10.1016/j.ijantimicag.2006.11.00717303392
   PubMed Web of Science ®Google Scholar
• Miyachi H, Miki I, Aoyama N, et al. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan. HELICOBACTER. 2006;11(4):243–249. doi:10.1111/j.1523-5378.2006.00415.x16882327
   PubMed Web of Science ®Google Scholar
• Singh V, Mishra S, Rao GRK, et al. Evaluation of nested PCR in detection of helicobacter pylori targeting a highly conserved gene: HSP60. HELICOBACTER. 2008;13(1):30–34. doi:10.1111/j.1523-5378.2008.00573.x18205663
   PubMed Web of Science ®Google Scholar
• CLSI. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. In: Approved Standard–Third Edition. CLSI Document M45-A2. vol. Wayne, PA: Clinical and Laboratory Standards Institute; 2015.
   Google Scholar
• Shetty V, Lamichhane B, Tay CY, et al. High primary resistance to metronidazole and levofloxacin, and a moderate resistance to clarithromycin in Helicobacter pylori isolated from Karnataka patients. GUT PATHOG. 2019;11(1):1. doi:10.1186/s13099-019-0305-x30675188
   PubMed Web of Science ®Google Scholar
• HO S, EL TAN, CK SAM, GOH K. Clarithromycin resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Malaysia. J DIGEST DIS. 2010;11(2):101–105. doi:10.1111/j.1751-2980.2010.00423.x
   Web of Science ®Google Scholar
• Wang L. Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains. WORLD J GASTROENTERO. 2010;16(18):2272. doi:10.3748/wjg.v16.i18.2272
   Web of Science ®Google Scholar
• Perez-Perez GI. Accurate diagnosis of Helicobacter pylori. Culture, including transport. Gastroenterol Clin North Am. 2000;29(4):879–884. doi:10.1016/S0889-8553(05)70155-211190072
   PubMed Web of Science ®Google Scholar
• BJ HU, ZHAO FJ, ZL CHAI, et al. Prevalence and antibiotic resistance profi le of Helicobacter pylori in Shanghai. Chin J Infect Chemother. 2016;16(3):346–352.
   Google Scholar
• Wang YH, Li Z, Wang L, et al. A systematic review and meta‐analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori. Helicobacter. 2018;23(2):e12467. doi:10.1111/hel.1246729405526
   PubMed Web of Science ®Google Scholar
• Garcia M, Raymond J, Garnier M, Cremniter J, Burucoa C. Distribution of Spontaneous gyrA Mutations in 97 Fluoroquinolone-Resistant Helicobacter pylori Isolates Collected in France. Antimicrobial Agents and Chemotherapy. 2012;56(1):550–551. doi:10.1128/AAC.05243-1122064536
   PubMed Web of Science ®Google Scholar
• Boltin D, Ben-Zvi H, Perets TT, et al. Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned? J Clin Microbiol. 2015;53(2):522–527. doi:10.1128/JCM.03001-1425428158
   PubMed Web of Science ®Google Scholar
• Horiki N, Omata F, Uemura M, et al. Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan. HELICOBACTER. 2009;14(5):86–90. doi:10.1111/j.1523-5378.2009.00714.x19751432
   PubMed Web of Science ®Google Scholar
• Kim JJ, Reddy R, Lee M, et al. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother. 2001;47(4):459–461. doi:10.1093/jac/47.4.45911266421
   PubMed Web of Science ®Google Scholar
• Shiota S, Reddy R, Alsarraj A, El-Serag HB, Graham DY. Antibiotic resistance of helicobacter pylori among male united states veterans. Clin Gastroenterol Hepatol. 2015;13(9):1616–1624. doi:10.1016/j.cgh.2015.02.00525681693
   PubMed Web of Science ®Google Scholar
• Mitui M, Patel A, Leos NK, Doern CD, Park JY. Novel Helicobacter pylori sequencing test identifies high rate of clarithromycin resistance. J Pediatr Gastroenterol Nutr. 2014;59(1):6–9. doi:10.1097/MPG.000000000000038025222804
   PubMed Web of Science ®Google Scholar
• Saracino IM, Zullo A, Holton J, et al. High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy. J Gastrointestin Liver Dis. 2012;21(4):363–365.23256118
   PubMed Web of Science ®Google Scholar
• Cabrita J, Oleastro M, Matos R, et al. Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990–1999). J Antimicrob Chemother. 2000;46(6):1029–1031. doi:10.1093/jac/46.6.102911102427
   PubMed Web of Science ®Google Scholar
• Li L, Ke Y, Yu C, et al. Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter retrospective study over 7 years. HELICOBACTER. 2017;22(3):e12373. doi:10.1111/hel.12373
   Web of Science ®Google Scholar
• Bouihat N, Burucoa C, Benkirane A, et al. Helicobacter pylori primary antibiotic resistance in 2015 in morocco: a phenotypic and genotypic prospective and multicenter study. Microb Drug Resist. 2017;23(6):727–732. doi:10.1089/mdr.2016.026427996373
   PubMed Web of Science ®Google Scholar
• Miftahussurur M, Shrestha PK, Subsomwong P, Sharma RP, Yamaoka Y. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal. BMC Microbiol. 2016;16(1):1. doi:10.1186/s12866-016-0873-626728027
   PubMed Web of Science ®Google Scholar